Exact Sciences Revenue and Competitors

Madison, WI USA

Location

$1B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Exact Sciences's estimated annual revenue is currently $454.5M per year.(i)
  • Exact Sciences received $747.5M in venture funding in March 2019.
  • Exact Sciences's estimated revenue per employee is $68,629
  • Exact Sciences's total funding is $1B.

Employee Data

  • Exact Sciences has 6622 Employees.(i)
  • Exact Sciences grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$434.8M1865-14%$2B$2.7B
#2
$4280M11139-4%$28M$63.3B
#3
$343.9M31767%$550M$7.9B
#4
$423.6M17085%$2B$2.5B
Add Company

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences or find Exact Sciences on Facebook. For more information on Exact Sciences' noninvasive colon cancer screening test, visit CologuardTest.com

keywords:Biotechnology,Healthcare,Human Resources Hr,Medical Diagnostics,Pharmaceuticals

$1B

Total Funding

6622

Number of Employees

$454.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Exact Sciences's People

NameTitleEmail/Phone
1
SVP R&D and Chief Scientific OfficerReveal Email/Phone
2
Senior Director, Human ResourcesReveal Email/Phone
3
Senior Director, Commercial EffectivenessReveal Email/Phone
4
Recruiting CoordinatorReveal Email/Phone
5
Sr Convention Planning ManagerReveal Email/Phone
6
Principal Software EngineerReveal Email/Phone
7
Senior Human Resources Business PartnerReveal Email/Phone
8
General ManagerReveal Email/Phone
9
Commercial Program ManagerReveal Email/Phone
10
Senior Area Sales Manager, Women's HealthReveal Email/Phone

Exact Sciences News

2022-04-20 - Brokerages Anticipate Exact Sciences Co. (NASDAQ:EXAS ...

Brokerages Anticipate Exact Sciences Co. (NASDAQ:EXAS) Will Announce Quarterly Sales of $461.86 Million. Posted by admin on Apr 23rd, 2022.

2022-04-13 - Guardant Health, Exact Sciences Make Progress on Multi ...

NEW YORK – Exact Sciences and Guardant Health, two major players aiming for a share of the anticipated blood-based cancer screening market,...

2022-04-06 - Exact Sciences schedules first quarter 2022 earnings call

MADISON, Wis., April 8, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced...

2021-10-11 - Exact Sciences : Hosts Maydm Interns

Exact Sciences Hosts Maydm Interns This summer, Exact Sciences worked with Maydm, a community partner,to host four interns interested in science, technology, engineering and math (STEM) fields. The internship program organized by Maydm gives high school students the opportunity to utilize previ ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1553M73953%N/A
#2
$1924.7M91652%N/A
#3
$2160.3M1028730%N/A
#4
N/A13386-6%N/A
#5
$6663M216334%N/A

Exact Sciences Funding

DateAmountRoundLead InvestorsReference
2003-08-18$15.0MMilestone FundingArticle
2009-06-12$8.2MUndisclosedArticle
2015-07-27$174.0MUndisclosedJefferiesArticle
2016-07-29$15.2MUndisclosedJefferies LLCArticle
2017-06-08$281.8MUndisclosedJefferies LLCArticle
2018-01-12$500.0MUndisclosedBofA Merrill LynchArticle
2019-03-07$747.5MUndisclosedBofA Merrill LynchArticle